Edition:
United States

Kindred Biosciences Inc (KIN.OQ)

KIN.OQ on NASDAQ Stock Exchange Capital Market

8.60USD
23 Feb 2018
Change (% chg)

$0.10 (+1.18%)
Prev Close
$8.50
Open
$8.60
Day's High
$8.60
Day's Low
$8.40
Volume
6,572
Avg. Vol
15,460
52-wk High
$9.80
52-wk Low
$5.00

Chart for

About

Kindred Biosciences, Inc. is a development-stage biopharmaceutical company. The Company is focused on developing therapies for pets. The Company's product pipeline consists of small molecules and biologics for a range of indications in dogs, cats and horses. The Company is developing product candidates for over 20 indications... (more)

Overall

Beta: 0.10
Market Cap(Mil.): $242.16
Shares Outstanding(Mil.): 28.16
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 195.87 16.59
EPS (TTM): -- -- --
ROI: -- -0.71 35.07
ROE: -- -3.37 17.79

BRIEF-Kindred Biosciences Inc Files For Mixed Shelf Of Up To $150 Million

* KINDRED BIOSCIENCES INC FILES FOR MIXED SHELF OF UP TO $150 MILLION – SEC FILING‍​ Source text - (http://bit.ly/2risHPv) Further company coverage:

Jan 18 2018

BRIEF-KindredBio Announces Submission Of European Medicines Agency Filing For Mirataz

* KINDREDBIO ANNOUNCES SUBMISSION OF EUROPEAN MEDICINES AGENCY FILING FOR MIRATAZ™

Dec 21 2017

BRIEF-KindredBio Announces Positive Results From Pivotal Study Of Zimeta Oral

* KINDREDBIO ANNOUNCES POSITIVE RESULTS FROM PIVOTAL STUDY OF ZIMETA ORAL FOR FEVER IN HORSES

Dec 04 2017

BRIEF-Kindred Biosciences posts Q3 loss of $0.29 per share

* Kindred biosciences announces third quarter 2017 financial results

Nov 07 2017

Earnings vs. Estimates